Increased prevalence of diabetes mellitus in bullous pemphigoid patients during the last decade

J Eur Acad Dermatol Venereol. 2018 Apr;32(4):e153-e154. doi: 10.1111/jdv.14649. Epub 2017 Nov 7.

Authors

L Fania¹, G Di Zenzo¹, B Didona¹, M A Pilla¹, L Sobrino¹, A Panebianco¹, C Mazzanti¹, D Abeni¹

Affiliation

¹ Istituto Dermopatico dell'Immacolata-IRCCS, FLMM, Rome, Italy.

PMID: 29055144
DOI: 10.1111/jdv.14649

No abstract available

Publication types

Letter

MeSH terms

Diabetes Mellitus, Type 2 / drug therapy
Diabetes Mellitus, Type 2 / epidemiology*
Dipeptidyl-Peptidase IV Inhibitors / adverse effects
Dipeptidyl-Peptidase IV Inhibitors / therapeutic use
Humans
Pemphigoid, Bullous / complications*
Prevalence

Substances

Dipeptidyl-Peptidase IV Inhibitors